← Leaderboards
William J Gibson
Harvard Medical School
$121,399
Attributed
$121,399
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $48.6K · FY2015–17$50K$37.5K$25K$12.5K$0
'15
'16
'17
Funding mix
By agency
NIH$121,399 · 1
By mechanism
F30$121,399 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Norbert Perrimon$95,273,017
- Ulrich H Von Andrian$44,950,919
- Bernardo L Sabatini$25,331,480
- Steven P Gygi$23,279,525
- Arlene H Sharpe$68,359,602
Others in their field
Top investigators on “Engineering”
- David Heimbrook · Leidos Biomedical Research, Inc.$265,348,415
- Francis L Halzen · University Of Wisconsin-Madison$239,306,664
- Lisa Garcia Bedolla · University Of California-Berkeley$175,927,128
- Daniel Stanzione · Arizona State University$173,674,275
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$173,157,760
- Kiyoshi Suyehiro · Iodp Management International, Inc$166,539,344
Research focus
EngineeringEssential GenesApoptosisEffective TherapyBuffersCancer CellCancer Cell LineBiologyBreast Cancer CellDrug DesignCancer TypeCell CountCell Cycle ProgressionCell LineCell PhysiologyCellsCancer GenomeComplexCancer PatientCytotoxicityCancer TherapyDiploidyDiploid CellsEvent
Grant awards (3)
Hemizygous deletion of esential genes enables a novel therqpeutic vulnerability in cancer$24,703
F30 · FY2017 · CA · contact PI
Hemizygous deletion of esential genes enables a novel therqpeutic vulnerability in cancer$48,576
F30 · FY2016 · CA · contact PI
Hemizygous deletion of esential genes enables a novel therqpeutic vulnerability in cancer$48,120
F30 · FY2015 · CA · contact PI